Skip to main content
. 2019 May 28;116(24):11978–11987. doi: 10.1073/pnas.1819992116

Fig. 4.

Fig. 4.

CD33 deletion protects CD34+ cells from CART33 cytotoxicity in vitro. (A) Schematic of CART33 construct. (B) Contour plot showing CAR expression in human primary T cells after lentiviral transduction with control (black) or CART33 (green or blue) virus. Percentage transduction in each group is specified next to the plots. CD4+ and CD8+ cells were transduced independently and comixed 1:1 before experiment. (CF) Cytotoxicity assays. (C) CART33 cells or control T were incubated with HL-60 or CD34+CD33WT or CD34+CD33Del and cytotoxicity assessed by flow cytometry. (DF) Triple culture cytotoxicity assay. CART33 cells or control T cells were coincubated with (D) HL-60 and CD34+CD33WT or (E) with HL-60 and CD34+CD33Del or (F) with CD34+CD33WT and CD34+CD33Del cells (four independent experiments).